# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4131107 | F | Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay | Homo sapiens | 11 | ALA4130351 | cell-based format | Scientific Literature | |
2. | ALA4131108 | F | Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by MTT assay | Homo sapiens | 11 | ALA4130351 | cell-based format | Scientific Literature | |
3. | ALA4131111 | F | Induction of apoptosis in human HepG2 cells at 0.4 uM after 24 hrs by Annexin V/propidium iodide double staining-based flow cytometry (Rvb = 0.84%) | Homo sapiens | 1 | ALA4130351 | cell-based format | Scientific Literature | |
4. | ALA4131112 | F | Induction of apoptosis in human HepG2 cells at 0.4 uM after 48 hrs by Annexin V/propidium iodide double staining-based flow cytometry (Rvb = 0.84%) | Homo sapiens | 1 | ALA4130351 | cell-based format | Scientific Literature | |
5. | ALA4131115 | F | Cell cycle arrest in human HepG2 cells assessed as accumulation at G0/G1 phase at 0.4 uM after 24 hrs by propidium iodide staining-based flow cytometry (Rvb = 73.11%) | Homo sapiens | 1 | ALA4130351 | cell-based format | Scientific Literature | |
6. | ALA4131116 | F | Cell cycle arrest in human HepG2 cells assessed as accumulation at G0/G1 phase at 0.4 uM after 48 hrs by propidium iodide staining-based flow cytometry (Rvb = 73.11%) | Homo sapiens | 1 | ALA4130351 | cell-based format | Scientific Literature | |
7. | ALA4131119 | F | Cell cycle arrest in human HepG2 cells assessed as accumulation at S phase at 0.4 uM after 24 hrs by propidium iodide staining-based flow cytometry (Rvb = 21.69%) | Homo sapiens | 1 | ALA4130351 | cell-based format | Scientific Literature | |
8. | ALA4131120 | F | Cell cycle arrest in human HepG2 cells assessed as accumulation at S phase at 0.4 uM after 48 hrs by propidium iodide staining-based flow cytometry (Rvb = 21.69%) | Homo sapiens | 1 | ALA4130351 | cell-based format | Scientific Literature | |
9. | ALA4131123 | F | Cell cycle arrest in human HepG2 cells assessed as accumulation at G2/M phase at 0.4 uM after 24 hrs by propidium iodide staining-based flow cytometry (Rvb = 4.36%) | Homo sapiens | 1 | ALA4130351 | cell-based format | Scientific Literature | |
10. | ALA4131124 | F | Cell cycle arrest in human HepG2 cells assessed as accumulation at G2/M phase at 0.4 uM after 48 hrs by propidium iodide staining-based flow cytometry (Rvb = 4.36%) | Homo sapiens | 1 | ALA4130351 | cell-based format | Scientific Literature | |
11. | ALA4131133 | F | Induction of apoptosis in human HepG2 cells assessed as viable cells at 0.4 uM after 24 hrs by Annexin V/propidium iodide double staining-based flow cytometry (Rvb = 99.16 %) | Homo sapiens | 1 | ALA4130351 | cell-based format | Scientific Literature | |
12. | ALA4131134 | F | Induction of apoptosis in human HepG2 cells assessed as early apoptotic cells at 0.4 uM after 24 hrs by Annexin V/propidium iodide double staining-based flow cytometry (Rvb = 0.61 %) | Homo sapiens | 1 | ALA4130351 | cell-based format | Scientific Literature | |
13. | ALA4131135 | F | Induction of apoptosis in human HepG2 cells assessed as late apoptotic cells at 0.4 uM after 24 hrs by Annexin V/propidium iodide double staining-based flow cytometry (Rvb = 0.14 %) | Homo sapiens | 1 | ALA4130351 | cell-based format | Scientific Literature | |
14. | ALA4131136 | F | Induction of apoptosis in human HepG2 cells assessed as necrotic cells at 0.4 uM after 24 hrs by Annexin V/propidium iodide double staining-based flow cytometry (Rvb = 0.09 %) | Homo sapiens | 1 | ALA4130351 | cell-based format | Scientific Literature | |
15. | ALA4131137 | F | Induction of apoptosis in human HepG2 cells assessed as viable cells at 0.4 uM after 48 hrs by Annexin V/propidium iodide double staining-based flow cytometry (Rvb = 99.16 %) | Homo sapiens | 1 | ALA4130351 | cell-based format | Scientific Literature | |
16. | ALA4131138 | F | Induction of apoptosis in human HepG2 cells assessed as early apoptotic cells at 0.4 uM after 48 hrs by Annexin V/propidium iodide double staining-based flow cytometry (Rvb = 0.61 %) | Homo sapiens | 1 | ALA4130351 | cell-based format | Scientific Literature | |
17. | ALA4131139 | F | Induction of apoptosis in human HepG2 cells assessed as late apoptotic cells at 0.4 uM after 48 hrs by Annexin V/propidium iodide double staining-based flow cytometry (Rvb = 0.14 %) | Homo sapiens | 1 | ALA4130351 | cell-based format | Scientific Literature | |
18. | ALA4131140 | F | Induction of apoptosis in human HepG2 cells assessed as necrotic cells at 0.4 uM after 48 hrs by Annexin V/propidium iodide double staining-based flow cytometry (Rvb = 0.09 %) | Homo sapiens | 1 | ALA4130351 | cell-based format | Scientific Literature | |
19. | ALA4131142 | F | Induction of apoptosis in human HepG2 cells assessed as caspase-3 activation at 0.4 uM after 10 mins by ELISA relative to control | Homo sapiens | 1 | ALA4130351 | cell-based format | Scientific Literature | |
20. | ALA4131143 | B | Inhibition of CDK2 (unknown origin) at 0.004 uM by CDKN2A antibody-based spectrophotometry | Homo sapiens | 1 | ALA4130351 | single protein format | Scientific Literature |